Please Wait
Applying Filters...
menu
    • menu
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    CKD-330 COMPONENT AMLODIPINE

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CMP Pharma Launches Alcohol-Free Norliqva Oral Solution
    CMP Pharma Launches Alcohol-Free Norliqva Oral Solution

    20 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cmp-pharma-announces-availability-of-a-new-alcohol-free-reformulation-of-norliqva-amlodipine-oral-solution-302746717.html

    PR NEWSWIRE
    20 Apr 2026
    Share Share
    Pangea Pharma Launches Sdamlo, First FDA-Approved Amlodipine
    Pangea Pharma Launches Sdamlo, First FDA-Approved Amlodipine

    15 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-15/pangea-pharmaceuticals-announces-us-launch-of-sdamlo-the-first-and-only-fda-approved-amlodipine

    PHARMIWEB
    15 Apr 2026
    Share Share
    Piramal Pharma Backs George Medicines in Hypertension Drug
    Piramal Pharma Backs George Medicines in Hypertension Drug

    29 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/piramal-pharma-solutions-supports-george-medicines-in-developing-its-new-drug-for-hypertension-widaplik-telmisartan-amlodipine-and-indapamide-302541305.html

    PR NEWSWIRE
    29 Aug 2025
    Share Share
    Enforcement Report - Week of August 20, 2025
    Enforcement Report - Week of August 20, 2025

    20 Aug 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-20-2025-4773.pdf

    FDA
    20 Aug 2025
    Share Share
    Enforcement Report - Week of August 6, 2025
    Enforcement Report - Week of August 6, 2025

    06 Aug 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-6-2025-14145.pdf

    FDA
    06 Aug 2025
    Share Share
    Veristat Congratulate George Medicine on FDA Approval of Widaplik
    Veristat Congratulate George Medicine on FDA Approval of Widaplik

    16 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250616203834/en/Veristat-Congratulates-George-Medicines-on-FDA-Approval-of-WIDAPLIK

    BUSINESSWIRE
    16 Jun 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.